Anthony Tennyson

Canadian biotech firm Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) filed for a new patent late last month in connection with ongoing research and...

In another sign of the industry’s shifting landscape and uncertain future of the treatment clinic model, Awakn Life Sciences has sold its last clinic and...

Toronto-based Awakn Life Sciences Corp. (OTC: AWKNF), a biotech company focused on addiction treatments, reported a heft 534% rise in annual revenue for the fiscal...

 Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with...

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) posted positive results as revenue rose along with patients — showing the growing demand for psychedelics-centered therapy...

Psychedelic Invest’s first Investor Hotseat livestream was broadcasted live on Thursday, May 26th. Host, Dustin Robinson, of Iter Investments, was joined by Anthony Tennyson of ...

Those that couldn’t attend the Investor Hotseat event with Awakn ($AWKN) CEO Anthony Tennyson missed out on some key information regarding the company’s position, runway,...